X4 Pharmaceuticals, Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
X4 Pharmaceuticals, Inc has filed 800 SEC EDGAR filings since 24 Sep 2010

SEC filing history

Showing 276-300 of 800 matching filings.

Per page
25
Current page
12
D File 021-483142

D filing

Filing date
01 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 May 2023
Reporting date
31 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38295

144 filing

Filing date
31 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90199

GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1

Filing date
26 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38295

DEFA14A

Filing date
27 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38295

ARS

Filing date
25 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38295

DEFA14A

Filing date
25 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38295

DEF 14A

Filing date
25 Apr 2023
Reporting date
25 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Mar 2023
Reporting date
10 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Mar 2023
Reporting date
10 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Mar 2023
Reporting date
10 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Mar 2023
Reporting date
10 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Feb 2023
Reporting date
13 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Feb 2023
Reporting date
13 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Feb 2023
Reporting date
13 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .